PDLIM2 and COVID-19: In summary, our study demonstrates that low PDLIM2 expression in the context of influenza and COVID-19 correlates with unfavorable molecular and cellular profiles of pro-inflammation and pro-fibrosis and cell injury, and is associated with increased disease severity.